| Symbol |
Name |
|
A2M
|
alpha-2-macroglobulin
|
|
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1
|
|
ABCA2
|
ATP-binding cassette, sub-family A (ABC1), member 2
|
|
ABCA7
|
ATP-binding cassette, sub-family A (ABC1), member 7
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCC8
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACHE
|
acetylcholinesterase (Yt blood group)
|
|
ACTA1
|
actin, alpha 1, skeletal muscle
|
|
ACTA2
|
actin, alpha 2, smooth muscle, aorta
|
|
ACTN4
|
actinin, alpha 4
|
|
ACVRL1
|
activin A receptor type II-like 1
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
ADAR
|
adenosine deaminase, RNA-specific
|
|
ADARB1
|
adenosine deaminase, RNA-specific, B1
|
|
ADCK3
|
aarF domain containing kinase 3
|
|
ADCY5
|
adenylate cyclase 5
|
|
ADORA2A
|
adenosine A2a receptor
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AIP
|
aryl hydrocarbon receptor interacting protein
|
|
AKR1B10
|
aldo-keto reductase family 1, member B10 (aldose reductase)
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALAS2
|
5'-aminolevulinate synthase 2
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ALOX5
|
arachidonate 5-lipoxygenase
|
|
ALPL
|
alkaline phosphatase, liver/bone/kidney
|
|
AMACR
|
alpha-methylacyl-CoA racemase
|
|
ANKH
|
ANKH inorganic pyrophosphate transport regulator
|
|
ANOS1
|
anosmin 1
|
|
ANPEP
|
alanyl (membrane) aminopeptidase
|
|
ANXA10
|
annexin A10
|
|
APC
|
adenomatous polyposis coli
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
|
APH1A
|
APH1A gamma secretase subunit
|
|
APOC3
|
apolipoprotein C-III
|
|
APOD
|
apolipoprotein D
|
|
APOE
|
apolipoprotein E
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
APTX
|
aprataxin
|
|
AR
|
androgen receptor
|
|
ARID1A
|
AT rich interactive domain 1A (SWI-like)
|
|
ARL11
|
ADP-ribosylation factor-like 11
|
|
ATL1
|
atlastin GTPase 1
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP1A1
|
ATPase, Na+/K+ transporting, alpha 1 polypeptide
|
|
ATP1A2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide
|
|
ATP1A3
|
ATPase, Na+/K+ transporting, alpha 3 polypeptide
|
|
ATP2B3
|
ATPase, Ca++ transporting, plasma membrane 3
|
|
ATP2C1
|
ATPase, Ca++ transporting, type 2C, member 1
|
|
ATRX
|
alpha thalassemia/mental retardation syndrome X-linked
|
|
ATXN2
|
ataxin 2
|
|
ATXN3
|
ataxin 3
|
|
AURKA
|
aurora kinase A
|
|
AXIN2
|
axin 2
|
|
BACE1
|
beta-site APP-cleaving enzyme 1
|
|
BACE2
|
beta-site APP-cleaving enzyme 2
|
|
BAG3
|
BCL2-associated athanogene 3
|
|
BAP1
|
BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)
|
|
BCCIP
|
BRCA2 and CDKN1A interacting protein
|
|
BCHE
|
butyrylcholinesterase
|
|
BIK
|
BCL2-interacting killer (apoptosis-inducing)
|
|
BIN1
|
bridging integrator 1
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BIRC7
|
baculoviral IAP repeat containing 7
|
|
BLM
|
Bloom syndrome, RecQ helicase-like
|
|
BMPR2
|
bone morphogenetic protein receptor, type II (serine/threonine kinase)
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRCA3
|
breast cancer 3
|
|
BSCL2
|
Berardinelli-Seip congenital lipodystrophy 2 (seipin)
|
|
BST1
|
bone marrow stromal cell antigen 1
|
|
BTBD10
|
BTB (POZ) domain containing 10
|
|
BTLA
|
B and T lymphocyte associated
|
|
BTNL2
|
butyrophilin-like 2
|
|
C10ORF2
|
chromosome 10 open reading frame 2
|
|
C11ORF30
|
chromosome 11 open reading frame 30
|
|
C1GALT1C1
|
C1GALT1-specific chaperone 1
|
|
C9ORF72
|
chromosome 9 open reading frame 72
|
|
CAB39
|
calcium binding protein 39
|
|
CACNA1A
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
|
|
CACNA1S
|
calcium channel, voltage-dependent, L type, alpha 1S subunit
|
|
CALHM1
|
calcium homeostasis modulator 1
|
|
CARD14
|
caspase recruitment domain family, member 14
|
|
CASP6
|
caspase 6, apoptosis-related cysteine peptidase
|
|
CAST
|
calpastatin
|
|
CAT
|
catalase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CAV3
|
caveolin 3
|
|
CCDC62
|
coiled-coil domain containing 62
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCM2
|
cerebral cavernous malformation 2
|
|
CCND1
|
cyclin D1
|
|
CCNE1
|
cyclin E1
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CCS
|
copper chaperone for superoxide dismutase
|
|
CD2
|
CD2 molecule
|
|
CD28
|
CD28 molecule
|
|
CD33
|
CD33 molecule
|
|
CD36
|
CD36 molecule (thrombospondin receptor)
|
|
CD38
|
CD38 molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD47
|
CD47 molecule
|
|
CDC73
|
cell division cycle 73
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CDKN2C
|
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4)
|
|
CDKN2D
|
cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4)
|
|
CFH
|
complement factor H
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHGB
|
chromogranin B
|
|
CHMP2B
|
charged multivesicular body protein 2B
|
|
CHN1
|
chimerin 1
|
|
CHRNA3
|
cholinergic receptor, nicotinic, alpha 3 (neuronal)
|
|
CHRNA4
|
cholinergic receptor, nicotinic, alpha 4 (neuronal)
|
|
CHRNB4
|
cholinergic receptor, nicotinic, beta 4 (neuronal)
|
|
CHST14
|
carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14
|
|
CLDN1
|
claudin 1
|
|
CLU
|
clusterin
|
|
CNTF
|
ciliary neurotrophic factor
|
|
COL1A2
|
collagen, type I, alpha 2
|
|
COL4A1
|
collagen, type IV, alpha 1
|
|
COL4A2
|
collagen, type IV, alpha 2
|
|
COMT
|
catechol-O-methyltransferase
|
|
COQ2
|
coenzyme Q2 4-hydroxybenzoate polyprenyltransferase
|
|
CPA6
|
carboxypeptidase A6
|
|
CR1
|
complement component (3b/4b) receptor 1 (Knops blood group)
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
|
CST3
|
cystatin C
|
|
CTBP2
|
C-terminal binding protein 2
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTNNBIP1
|
catenin, beta interacting protein 1
|
|
CTSD
|
cathepsin D
|
|
CUL3
|
cullin 3
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP27A1
|
cytochrome P450, family 27, subfamily A, polypeptide 1
|
|
CYP27B1
|
cytochrome P450, family 27, subfamily B, polypeptide 1
|
|
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP46A1
|
cytochrome P450, family 46, subfamily A, polypeptide 1
|
|
CYP7B1
|
cytochrome P450, family 7, subfamily B, polypeptide 1
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DAXX
|
death-domain associated protein
|
|
DCTN1
|
dynactin 1
|
|
DEFB103B
|
defensin, beta 103B
|
|
DICER1
|
dicer 1, ribonuclease type III
|
|
DISC1
|
disrupted in schizophrenia 1
|
|
DMD
|
dystrophin
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
DPP6
|
dipeptidyl-peptidase 6
|
|
DSP
|
desmoplakin
|
|
DUSP6
|
dual specificity phosphatase 6
|
|
ECE1
|
endothelin converting enzyme 1
|
|
EDN3
|
endothelin 3
|
|
EDNRB
|
endothelin receptor type B
|
|
EFNB1
|
ephrin-B1
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGLN1
|
egl-9 family hypoxia-inducible factor 1
|
|
EIF4G1
|
eukaryotic translation initiation factor 4 gamma, 1
|
|
ELAC2
|
elaC ribonuclease Z 2
|
|
ELANE
|
elastase, neutrophil expressed
|
|
ELN
|
elastin
|
|
ELOVL4
|
ELOVL fatty acid elongase 4
|
|
ENG
|
endoglin
|
|
ENPP1
|
ectonucleotide pyrophosphatase/phosphodiesterase 1
|
|
EPAS1
|
endothelial PAS domain protein 1
|
|
EPB41L3
|
erythrocyte membrane protein band 4.1-like 3
|
|
EPHB2
|
EPH receptor B2
|
|
EPHB4
|
EPH receptor B4
|
|
EPHX1
|
epoxide hydrolase 1, microsomal (xenobiotic)
|
|
EPO
|
erythropoietin
|
|
EPOR
|
erythropoietin receptor
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
EXT1
|
exostosin glycosyltransferase 1
|
|
EXT2
|
exostosin glycosyltransferase 2
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
FANCA
|
Fanconi anemia, complementation group A
|
|
FANCB
|
Fanconi anemia, complementation group B
|
|
FANCD2
|
Fanconi anemia, complementation group D2
|
|
FBN1
|
fibrillin 1
|
|
FBXW4
|
F-box and WD repeat domain containing 4
|
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase
|
|
FGB
|
fibrinogen beta chain
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGGY
|
FGGY carbohydrate kinase domain containing
|
|
FH
|
fumarate hydratase
|
|
FHIT
|
fragile histidine triad
|
|
FHL1
|
four and a half LIM domains 1
|
|
FHL2
|
four and a half LIM domains 2
|
|
FIGLA
|
folliculogenesis specific basic helix-loop-helix
|
|
FKRP
|
fukutin related protein
|
|
FLCN
|
folliculin
|
|
FMR1
|
fragile X mental retardation 1
|
|
FOXC2
|
forkhead box C2
|
|
FOXE1
|
forkhead box E1
|
|
FOXL2
|
forkhead box L2
|
|
FOXP1
|
forkhead box P1
|
|
FPR2
|
formyl peptide receptor 2
|
|
FRK
|
fyn-related Src family tyrosine kinase
|
|
FSHR
|
follicle stimulating hormone receptor
|
|
FTO
|
fat mass and obesity associated
|
|
FUS
|
FUS RNA binding protein
|
|
FUT1
|
fucosyltransferase 1 (galactoside 2-alpha-L-fucosyltransferase, H blood group)
|
|
FUT2
|
fucosyltransferase 2 (secretor status included)
|
|
FUT3
|
fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group)
|
|
FXN
|
frataxin
|
|
GAB2
|
GRB2-associated binding protein 2
|
|
GABBR1
|
gamma-aminobutyric acid (GABA) B receptor, 1
|
|
GADD45A
|
growth arrest and DNA-damage-inducible, alpha
|
|
GAK
|
cyclin G associated kinase
|
|
GARS
|
glycyl-tRNA synthetase
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GATA2
|
GATA binding protein 2
|
|
GATA3
|
GATA binding protein 3
|
|
GATA4
|
GATA binding protein 4
|
|
GBA
|
glucosidase, beta, acid
|
|
GCH1
|
GTP cyclohydrolase 1
|
|
GDAP1
|
ganglioside induced differentiation associated protein 1
|
|
GDF6
|
growth differentiation factor 6
|
|
GDNF
|
glial cell derived neurotrophic factor
|
|
GHRH
|
growth hormone releasing hormone
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GJB3
|
gap junction protein, beta 3, 31kDa
|
|
GJB6
|
gap junction protein, beta 6, 30kDa
|
|
GKN1
|
gastrokine 1
|
|
GLA
|
galactosidase, alpha
|
|
GLI3
|
GLI family zinc finger 3
|
|
GNAL
|
guanine nucleotide binding protein (G protein), alpha activating activity polypeptide, olfactory type
|
|
GNAS
|
GNAS complex locus
|
|
GNE
|
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase
|
|
GOLM1
|
golgi membrane protein 1
|
|
GPX1
|
glutathione peroxidase 1
|
|
GREM1
|
gremlin 1, DAN family BMP antagonist
|
|
GRIN2A
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2A
|
|
GRK5
|
G protein-coupled receptor kinase 5
|
|
GRN
|
granulin
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTO1
|
glutathione S-transferase omega 1
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
H2AFX
|
H2A histone family, member X
|
|
HCRTR1
|
hypocretin (orexin) receptor 1
|
|
HCRTR2
|
hypocretin (orexin) receptor 2
|
|
HDAC11
|
histone deacetylase 11
|
|
HECTD2
|
HECT domain containing E3 ubiquitin protein ligase 2
|
|
HES7
|
hes family bHLH transcription factor 7
|
|
HESX1
|
HESX homeobox 1
|
|
HFE
|
hemochromatosis
|
|
HIC1
|
hypermethylated in cancer 1
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-DRA
|
major histocompatibility complex, class II, DR alpha
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-DRB3
|
major histocompatibility complex, class II, DR beta 3
|
|
HMGA1
|
high mobility group AT-hook 1
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HMOX1
|
heme oxygenase 1
|
|
HNF1A
|
HNF1 homeobox A
|
|
HNF1B
|
HNF1 homeobox B
|
|
HOXA1
|
homeobox A1
|
|
HOXA2
|
homeobox A2
|
|
HOXB13
|
homeobox B13
|
|
HOXB3
|
homeobox B3
|
|
HOXD3
|
homeobox D3
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSD17B10
|
hydroxysteroid (17-beta) dehydrogenase 10
|
|
HSF1
|
heat shock transcription factor 1
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HSPB7
|
heat shock 27kDa protein family, member 7 (cardiovascular)
|
|
HSPD1
|
heat shock 60kDa protein 1 (chaperonin)
|
|
HTR1A
|
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled
|
|
HTRA2
|
HtrA serine peptidase 2
|
|
ID4
|
inhibitor of DNA binding 4, dominant negative helix-loop-helix protein
|
|
IDE
|
insulin-degrading enzyme
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IDI1
|
isopentenyl-diphosphate delta isomerase 1
|
|
IDI2
|
isopentenyl-diphosphate delta isomerase 2
|
|
IFNG
|
interferon, gamma
|
|
IGFBP2
|
insulin-like growth factor binding protein 2, 36kDa
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGHMBP2
|
immunoglobulin mu binding protein 2
|
|
IL10
|
interleukin 10
|
|
IL17A
|
interleukin 17A
|
|
IL18
|
interleukin 18
|
|
IL1B
|
interleukin 1, beta
|
|
IL5RA
|
interleukin 5 receptor, alpha
|
|
IL6
|
interleukin 6
|
|
ILK
|
integrin-linked kinase
|
|
ING1
|
inhibitor of growth family, member 1
|
|
INS
|
insulin
|
|
IRF6
|
interferon regulatory factor 6
|
|
ISL1
|
ISL LIM homeobox 1
|
|
ITGAV
|
integrin, alpha V
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
ITGB8
|
integrin, beta 8
|
|
JAK2
|
Janus kinase 2
|
|
KCNJ5
|
potassium channel, inwardly rectifying subfamily J, member 5
|
|
KCNT1
|
potassium channel, sodium activated subfamily T, member 1
|
|
KDR
|
kinase insert domain receptor
|
|
KHDC3L
|
KH domain containing 3-like, subcortical maternal complex member
|
|
KIF24
|
kinesin family member 24
|
|
KIFAP3
|
kinesin-associated protein 3
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KLF6
|
Kruppel-like factor 6
|
|
KLK4
|
kallikrein-related peptidase 4
|
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRIT1
|
KRIT1, ankyrin repeat containing
|
|
KRT19
|
keratin 19, type I
|
|
KRT5
|
keratin 5, type II
|
|
KRT6A
|
keratin 6A, type II
|
|
LAMP2
|
lysosomal-associated membrane protein 2
|
|
LDLR
|
low density lipoprotein receptor
|
|
LEMD3
|
LEM domain containing 3
|
|
LEPR
|
leptin receptor
|
|
LGI1
|
leucine-rich, glioma inactivated 1
|
|
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1
|
|
LINGO1
|
leucine rich repeat and Ig domain containing 1
|
|
LMNA
|
lamin A/C
|
|
LOC643387
|
TAR DNA binding protein pseudogene
|
|
LPL
|
lipoprotein lipase
|
|
LRP1
|
low density lipoprotein receptor-related protein 1
|
|
LRP8
|
low density lipoprotein receptor-related protein 8, apolipoprotein e receptor
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
MAGED1
|
melanoma antigen family D1
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPT
|
microtubule-associated protein tau
|
|
MAX
|
MYC associated factor X
|
|
MC1R
|
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)
|
|
MCF2
|
MCF.2 cell line derived transforming sequence
|
|
MCHR1
|
melanin-concentrating hormone receptor 1
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MECOM
|
MDS1 and EVI1 complex locus
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MED12
|
mediator complex subunit 12
|
|
MEN1
|
multiple endocrine neoplasia I
|
|
MESP2
|
mesoderm posterior basic helix-loop-helix transcription factor 2
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MID1
|
midline 1
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR106A
|
microRNA 106a
|
|
MIR148A
|
microRNA 148a
|
|
MIR152
|
microRNA 152
|
|
MIR17
|
microRNA 17
|
|
MIR18B
|
microRNA 18b
|
|
MIR205
|
microRNA 205
|
|
MIR221
|
microRNA 221
|
|
MIR222
|
microRNA 222
|
|
MIR27A
|
microRNA 27a
|
|
MIR29A
|
microRNA 29a
|
|
MIR29B1
|
microRNA 29b-1
|
|
MIR338
|
microRNA 338
|
|
MIR34B
|
microRNA 34b
|
|
MKRN3
|
makorin ring finger protein 3
|
|
MLH1
|
mutL homolog 1
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MNX1
|
motor neuron and pancreas homeobox 1
|
|
MSH2
|
mutS homolog 2
|
|
MSH3
|
mutS homolog 3
|
|
MSH6
|
mutS homolog 6
|
|
MST1
|
macrophage stimulating 1
|
|
MSX1
|
msh homeobox 1
|
|
MT-TL1
|
tRNA
|
|
MT1X
|
metallothionein 1X
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTMR14
|
myotubularin related protein 14
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MTR
|
5-methyltetrahydrofolate-homocysteine methyltransferase
|
|
MTRR
|
5-methyltetrahydrofolate-homocysteine methyltransferase reductase
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC5B
|
mucin 5B, oligomeric mucus/gel-forming
|
|
MUTYH
|
mutY homolog
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYH11
|
myosin, heavy chain 11, smooth muscle
|
|
MYH3
|
myosin, heavy chain 3, skeletal muscle, embryonic
|
|
N4BP2
|
NEDD4 binding protein 2
|
|
NAT1
|
N-acetyltransferase 1 (arylamine N-acetyltransferase)
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
NBN
|
nibrin
|
|
NCOA3
|
nuclear receptor coactivator 3
|
|
NCSTN
|
nicastrin
|
|
NDEL1
|
nudE neurodevelopment protein 1-like 1
|
|
NEFH
|
neurofilament, heavy polypeptide
|
|
NF1
|
neurofibromin 1
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFIB
|
nuclear factor I/B
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NGF
|
nerve growth factor (beta polypeptide)
|
|
NIPBL
|
Nipped-B homolog (Drosophila)
|
|
NKX2-1
|
NK2 homeobox 1
|
|
NKX2-3
|
NK2 homeobox 3
|
|
NKX2-5
|
NK2 homeobox 5
|
|
NLRP7
|
NLR family, pyrin domain containing 7
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NODAL
|
nodal growth differentiation factor
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NOTCH3
|
notch 3
|
|
NOTCH4
|
notch 4
|
|
NPC1
|
Niemann-Pick disease, type C1
|
|
NPHS1
|
nephrosis 1, congenital, Finnish type (nephrin)
|
|
NPHS2
|
nephrosis 2, idiopathic, steroid-resistant (podocin)
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NSDHL
|
NAD(P) dependent steroid dehydrogenase-like
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
NTRK3
|
neurotrophic tyrosine kinase, receptor, type 3
|
|
NUDT1
|
nudix (nucleoside diphosphate linked moiety X)-type motif 1
|
|
OCLN
|
occludin
|
|
ODC1
|
ornithine decarboxylase 1
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
OPA1
|
optic atrophy 1 (autosomal dominant)
|
|
OPTN
|
optineurin
|
|
OTX2
|
orthodenticle homeobox 2
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
PAEP
|
progestagen-associated endometrial protein
|
|
PALLD
|
palladin, cytoskeletal associated protein
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PARK7
|
parkinson protein 7
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PAX2
|
paired box 2
|
|
PAX6
|
paired box 6
|
|
PAX8
|
paired box 8
|
|
PAX9
|
paired box 9
|
|
PCDH19
|
protocadherin 19
|
|
PDCD1
|
programmed cell death 1
|
|
PDCD10
|
programmed cell death 10
|
|
PDE8B
|
phosphodiesterase 8B
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDPN
|
podoplanin
|
|
PEMT
|
phosphatidylethanolamine N-methyltransferase
|
|
PFN1
|
profilin 1
|
|
PGR
|
progesterone receptor
|
|
PHEX
|
phosphate regulating endopeptidase homolog, X-linked
|
|
PHF6
|
PHD finger protein 6
|
|
PHOX2B
|
paired-like homeobox 2b
|
|
PICALM
|
phosphatidylinositol binding clathrin assembly protein
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PINK1
|
PTEN induced putative kinase 1
|
|
PITX2
|
paired-like homeodomain 2
|
|
PITX3
|
paired-like homeodomain 3
|
|
PLA2G6
|
phospholipase A2, group VI (cytosolic, calcium-independent)
|
|
PLCE1
|
phospholipase C, epsilon 1
|
|
POLG
|
polymerase (DNA directed), gamma
|
|
PON1
|
paraoxonase 1
|
|
PON2
|
paraoxonase 2
|
|
PON3
|
paraoxonase 3
|
|
PRKAG2
|
protein kinase, AMP-activated, gamma 2 non-catalytic subunit
|
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha
|
|
PRNP
|
prion protein
|
|
PROK2
|
prokineticin 2
|
|
PROP1
|
PROP paired-like homeobox 1
|
|
PRPH2
|
peripherin 2 (retinal degeneration, slow)
|
|
PRRT2
|
proline-rich transmembrane protein 2
|
|
PSEN1
|
presenilin 1
|
|
PSEN2
|
presenilin 2
|
|
PSMB7
|
proteasome (prosome, macropain) subunit, beta type, 7
|
|
PTCH1
|
patched 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH
|
parathyroid hormone
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
|
PTPRG
|
protein tyrosine phosphatase, receptor type, G
|
|
PVRL1
|
poliovirus receptor-related 1 (herpesvirus entry mediator C)
|
|
RAB29
|
RAB29, member RAS oncogene family
|
|
RAB5A
|
RAB5A, member RAS oncogene family
|
|
RAD51
|
RAD51 recombinase
|
|
RAD51C
|
RAD51 paralog C
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RAPSN
|
receptor-associated protein of the synapse
|
|
RARB
|
retinoic acid receptor, beta
|
|
RASA1
|
RAS p21 protein activator (GTPase activating protein) 1
|
|
RASAL1
|
RAS protein activator like 1 (GAP1 like)
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RB1
|
retinoblastoma 1
|
|
RECQL4
|
RecQ protein-like 4
|
|
REEP1
|
receptor accessory protein 1
|
|
RET
|
ret proto-oncogene
|
|
RFC1
|
replication factor C (activator 1) 1, 145kDa
|
|
RHOBTB2
|
Rho-related BTB domain containing 2
|
|
RNASEL
|
ribonuclease L (2',5'-oligoisoadenylate synthetase-dependent)
|
|
RP1L1
|
retinitis pigmentosa 1-like 1
|
|
RPSA
|
ribosomal protein SA
|
|
RUNX3
|
runt-related transcription factor 3
|
|
RYR2
|
ryanodine receptor 2 (cardiac)
|
|
SALL1
|
spalt-like transcription factor 1
|
|
SCGB3A1
|
secretoglobin, family 3A, member 1
|
|
SCN4A
|
sodium channel, voltage gated, type IV alpha subunit
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SDHA
|
succinate dehydrogenase complex, subunit A, flavoprotein (Fp)
|
|
SDHAF2
|
succinate dehydrogenase complex assembly factor 2
|
|
SDHB
|
succinate dehydrogenase complex, subunit B, iron sulfur (Ip)
|
|
SDHC
|
succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa
|
|
SDHD
|
succinate dehydrogenase complex, subunit D, integral membrane protein
|
|
SELE
|
selectin E
|
|
SELL
|
selectin L
|
|
SELP
|
selectin P (granule membrane protein 140kDa, antigen CD62)
|
|
SEPT4
|
septin 4
|
|
SEPT9
|
septin 9
|
|
SERPINA3
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SETX
|
senataxin
|
|
SFN
|
stratifin
|
|
SFRP2
|
secreted frizzled-related protein 2
|
|
SFTPA1
|
surfactant protein A1
|
|
SGCE
|
sarcoglycan, epsilon
|
|
SH3BP2
|
SH3-domain binding protein 2
|
|
SHBG
|
sex hormone-binding globulin
|
|
SHH
|
sonic hedgehog
|
|
SHOX
|
short stature homeobox
|
|
SIGMAR1
|
sigma non-opioid intracellular receptor 1
|
|
SIRT1
|
sirtuin 1
|
|
SIX2
|
SIX homeobox 2
|
|
SKP1
|
S-phase kinase-associated protein 1
|
|
SLC10A2
|
solute carrier family 10 (sodium/bile acid cotransporter), member 2
|
|
SLC12A3
|
solute carrier family 12 (sodium/chloride transporter), member 3
|
|
SLC19A1
|
solute carrier family 19 (folate transporter), member 1
|
|
SLC1A2
|
solute carrier family 1 (glial high affinity glutamate transporter), member 2
|
|
SLC22A4
|
solute carrier family 22 (organic cation/zwitterion transporter), member 4
|
|
SLC25A4
|
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4
|
|
SLC26A4
|
solute carrier family 26 (anion exchanger), member 4
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC4A11
|
solute carrier family 4, sodium borate transporter, member 11
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC6A8
|
solute carrier family 6 (neurotransmitter transporter), member 8
|
|
SMAD2
|
SMAD family member 2
|
|
SMAD3
|
SMAD family member 3
|
|
SMAD4
|
SMAD family member 4
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
|
SMC1A
|
structural maintenance of chromosomes 1A
|
|
SMN1
|
survival of motor neuron 1, telomeric
|
|
SMN2
|
survival of motor neuron 2, centromeric
|
|
SMO
|
smoothened, frizzled class receptor
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SORL1
|
sortilin-related receptor, L(DLR class) A repeats containing
|
|
SORT1
|
sortilin 1
|
|
SOX10
|
SRY (sex determining region Y)-box 10
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SPAST
|
spastin
|
|
SPG11
|
spastic paraplegia 11 (autosomal recessive)
|
|
SPG7
|
spastic paraplegia 7 (pure and complicated autosomal recessive)
|
|
SPINK1
|
serine peptidase inhibitor, Kazal type 1
|
|
SPINT2
|
serine peptidase inhibitor, Kunitz type, 2
|
|
SQSTM1
|
sequestosome 1
|
|
SRD5A2
|
steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)
|
|
SREBF1
|
sterol regulatory element binding transcription factor 1
|
|
SRF
|
serum response factor (c-fos serum response element-binding transcription factor)
|
|
SSB
|
Sjogren syndrome antigen B (autoantigen La)
|
|
SST
|
somatostatin
|
|
SSTR2
|
somatostatin receptor 2
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STK11
|
serine/threonine kinase 11
|
|
STK39
|
serine threonine kinase 39
|
|
STMN2
|
stathmin 2
|
|
STRADA
|
STE20-related kinase adaptor alpha
|
|
STXBP1
|
syntaxin binding protein 1
|
|
SUFU
|
suppressor of fused homolog (Drosophila)
|
|
SYT11
|
synaptotagmin XI
|
|
T
|
T, brachyury homolog (mouse)
|
|
TARDBP
|
TAR DNA binding protein
|
|
TCF7L1
|
transcription factor 7-like 1 (T-cell specific, HMG-box)
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TCOF1
|
Treacher Collins-Franceschetti syndrome 1
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
TERT
|
telomerase reverse transcriptase
|
|
TF
|
transferrin
|
|
TFAM
|
transcription factor A, mitochondrial
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB2
|
transforming growth factor, beta 2
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TH
|
tyrosine hydroxylase
|
|
THAP1
|
THAP domain containing, apoptosis associated protein 1
|
|
THBS1
|
thrombospondin 1
|
|
TIMM8A
|
translocase of inner mitochondrial membrane 8 homolog A (yeast)
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TLL1
|
tolloid-like 1
|
|
TLR2
|
toll-like receptor 2
|
|
TLR4
|
toll-like receptor 4
|
|
TMEM127
|
transmembrane protein 127
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF11A
|
tumor necrosis factor receptor superfamily, member 11a, NFKB activator
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFRSF14
|
tumor necrosis factor receptor superfamily, member 14
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
|
TNFRSF6B
|
tumor necrosis factor receptor superfamily, member 6b, decoy
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TNFSF4
|
tumor necrosis factor (ligand) superfamily, member 4
|
|
TNNI2
|
troponin I type 2 (skeletal, fast)
|
|
TOMM40
|
translocase of outer mitochondrial membrane 40 homolog (yeast)
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TOR1A
|
torsin family 1, member A (torsin A)
|
|
TP53
|
tumor protein p53
|
|
TP53BP1
|
tumor protein p53 binding protein 1
|
|
TP63
|
tumor protein p63
|
|
TPM2
|
tropomyosin 2 (beta)
|
|
TPM3
|
tropomyosin 3
|
|
TREX1
|
three prime repair exonuclease 1
|
|
TRIM37
|
tripartite motif containing 37
|
|
TRPC6
|
transient receptor potential cation channel, subfamily C, member 6
|
|
TRPM4
|
transient receptor potential cation channel, subfamily M, member 4
|
|
TRPS1
|
trichorhinophalangeal syndrome I
|
|
TRPV4
|
transient receptor potential cation channel, subfamily V, member 4
|
|
TSC1
|
tuberous sclerosis 1
|
|
TSC2
|
tuberous sclerosis 2
|
|
TSHR
|
thyroid stimulating hormone receptor
|
|
TTBK1
|
tau tubulin kinase 1
|
|
TTN
|
titin
|
|
TYMS
|
thymidylate synthetase
|
|
UBB
|
ubiquitin B
|
|
UBE2H
|
ubiquitin-conjugating enzyme E2H
|
|
UBE3A
|
ubiquitin protein ligase E3A
|
|
UBQLN2
|
ubiquilin 2
|
|
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
|
|
UCP2
|
uncoupling protein 2 (mitochondrial, proton carrier)
|
|
UNC13A
|
unc-13 homolog A (C. elegans)
|
|
UNC5C
|
unc-5 homolog C (C. elegans)
|
|
UNC93A
|
unc-93 homolog A (C. elegans)
|
|
UROD
|
uroporphyrinogen decarboxylase
|
|
VAPB
|
VAMP (vesicle-associated membrane protein)-associated protein B and C
|
|
VCP
|
valosin containing protein
|
|
VDAC1
|
voltage-dependent anion channel 1
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VSX1
|
visual system homeobox 1
|
|
VTCN1
|
V-set domain containing T cell activation inhibitor 1
|
|
WDR36
|
WD repeat domain 36
|
|
WFS1
|
Wolfram syndrome 1 (wolframin)
|
|
WIF1
|
WNT inhibitory factor 1
|
|
WNT10B
|
wingless-type MMTV integration site family, member 10B
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
|
WNT7A
|
wingless-type MMTV integration site family, member 7A
|
|
WNT8B
|
wingless-type MMTV integration site family, member 8B
|
|
WT1
|
Wilms tumor 1
|
|
XPC
|
xeroderma pigmentosum, complementation group C
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
XRCC2
|
X-ray repair complementing defective repair in Chinese hamster cells 2
|
|
XRCC3
|
X-ray repair complementing defective repair in Chinese hamster cells 3
|
|
XRCC6
|
X-ray repair complementing defective repair in Chinese hamster cells 6
|
|
YWHAB
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta
|
|
YWHAH
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta
|
|
ZEB2
|
zinc finger E-box binding homeobox 2
|
|
ZFP57
|
ZFP57 zinc finger protein
|
|
ZIC3
|
Zic family member 3
|
